News
Regulators will soon “unleash a massive framework” for how vaccines are tested and approved, according to FDA Commissioner ...
Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet ...
Surgeons in southern California successfully completed the world's first-ever human bladder transplant on 41-year-old Oscar ...
With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...
The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...
US health regulators have given final approval to Novavax's COVID vaccine after an unusual delay and have placed new ...
The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.
The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax's COVID-19 vaccine, but only for certain ...
The FDA has approved Novavax’s COVID-19 vaccine, Nuvavoxid, for use in adults 65 and older and in individuals ages 12-64 who have at least one underlying health condition. The approval is based on ...
The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results